DELRAY BEACH, Fla.–(BUSINESS WIRE)–Stanton Optical, a leading retail brand under Now Optics and a national leader in affordable, full-service eye care, is expanding on-site clinical services to 35 locations nationwide in partnership with Physicians E…
Category: Business
National Vision Releases Annual Sustainability Report Highlighting 2024 Progress
DULUTH, Ga.–(BUSINESS WIRE)–National Vision, Inc., one of the largest optical retail companies in the U.S., released its 2024 Sustainability Report, “A World Worth Seeing.” The report focuses on the company’s performance across its Social, Employees,…
National Vision Celebrates 11 Years of Supporting NOSA Students with $7,000 in Scholarships
DULUTH, Ga.–(BUSINESS WIRE)–National Vision, Inc., one of the nation’s largest optical retailers providing quality, affordable eye care and eyewear, has awarded $7,000 in scholarships to three optometry students whose passion for community impact and…
Bausch + Lomb Announces Publication of Phase 3 Data on LUMIFY® Preservative Free Redness Reliever Eye Drops
VAUGHAN, Ontario–(BUSINESS WIRE)–Bausch + Lomb Corporation (NYSE/TSX: BLCO), a leading global eye health company dedicated to helping people see better to live better, today announced Ophthalmology and Therapy has published results from a phase 3 stu…
Exonate plans ‘CLEAR-DE’ Phase IIb clinical trial of lead candidate EXN407 for diabetic eye disease
CAMBRIDGE, England–(BUSINESS WIRE)–Exonate Ltd., a biotechnology company developing novel, non-invasive, small-molecule therapeutics for patients with retinal vascular diseases, today announced plans to initiate a Phase IIb clinical trial for its lea…
betterview Reaches 20,000 Eyes Treated in Four Years
WINTERTHUR, Switzerland–(BUSINESS WIRE)–betterview, a Swiss provider of refractive eye surgery, has announced that it has reached the milestone of 20,000 eyes treated since its founding in 2021. Since its launch, the company has built a network of te…
betterview verzeichnet 20'000 behandelte Augen in vier Jahren
WINTERTHUR, Schweiz–(BUSINESS WIRE)–betterview, ein Anbieter für refraktive Chirurgie in der Schweiz, gibt bekannt, dass das Unternehmen die Marke von 20’000 behandelten Augen erreicht hat. Der Meilenstein wurde seit der Gründung des Unternehmens im …
Affirm and New Look Vision Group partner to offer flexible payment options across leading eyewear retailers in Canada
TORONTO–(BUSINESS WIRE)–Affirm (NASDAQ: AFRM), the payment network that empowers consumers and helps merchants drive growth, and New Look Vision Group, a leading North American optical retailer with over 475 stores in the US and Canada, today announc…
Affirm et Groupe Vision New Look s’associent pour offrir des options de paiement flexibles dans les principales lunetteries au Canada
TORONTO–(BUSINESS WIRE)–Affirm (NASDAQ : AFRM), le réseau de paiement qui aide les consommateurs à acheter ce qu’ils souhaitenten toute liberté et soutient la croissance des marchands, et Groupe Vision New Look, un chef de file nord-américain des mag…
Myopic Macular Degeneration Market Analysis and Forecast Report 2025-2035 with Regeneron Pharmaceuticals, F. Hoffmann-La Roche, and Bayer Leading Innovations – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “Myopic Macular Degeneration Market – A Global and Regional Analysis: Focus on Regional and Country Analysis – Analysis and Forecast, 2025-2035” report has been added to ResearchAndMarkets.com’s offering. The global myopic …
Cloudbreak Pharma Inc. Announces Positive Phase 2 Results for CBT-004 in Patients with Vascularized Pinguecula
IRVINE, Calif.–(BUSINESS WIRE)– #clinicaltrials–Cloudbreak Pharma Inc. a clinical-stage ophthalmology company developing innovative therapies for ocular surface diseases, today announced positive topline results from its Phase 2 clinical trial evalu…
Ora Appoints Industry Veteran Bill Sharbaugh as Chairman of the Board of Directors
BOSTON–(BUSINESS WIRE)– #ClinicalResearch–Leading global ophthalmic CRO Ora announces appointment of pharmaceutical industry veteran Bill Sharbaugh as Chairman of Board of Directors.
Sightview Expands Leadership Bench, Appointing Vice Presidents of Client Operations and Product Management
DURHAM, N.C.–(BUSINESS WIRE)– #EHR–Sightview, the only EHR and practice management partner focused solely on eyecare, has appointed Melissa Wright and Casi Nestleroad as VPs.
EyeDura's Sustained-Release Eye Drop Technology Wins Double Industry Honors
NEW YORK–(BUSINESS WIRE)–EyeDura Therapeutics Inc. (www.eyedura.com), a developer of preservative-free sustained release ophthalmic therapies, announced that it received top recognition at two major industry forums among a field of innovative ophthal…
Golden Age Health e Innostellar Biotherapeutics siglano un accordo di collaborazione esclusiva decennale per accelerare lo sviluppo della terapia genica LX-101 contro le distrofie retiniche ereditarie causate da mutazione del gene RPE65 in Cina
SHANGHAI–(BUSINESS WIRE)–Golden Age Health Pte. Ltd. (“GAH”) e Innostellar Biotherapeutics Co., Ltd. (“Innostellar”) oggi hanno annunciato la sigla di un accordo esclusivo decennale riguardante servizi di promozione che concede a GAH i diritti esclus…
Golden Age Health e Innostellar Biotherapeutics assinam colaboração exclusiva de 10 anos para acelerar a terapia gênica LX-101 voltada a distrofias hereditárias de retina causadas por mutação no gene RPE 65 na China continental
XANGAI–(BUSINESS WIRE)–Golden Age Health Pte. Ltd. (“GAH”) e a Innostellar Biotherapeutics Co., Ltd. (“Innostellar”) anunciaram hoje um Contrato de Serviços Promocionais exclusivo por dez anos que concede à GAH direitos exclusivos para comercializar …
Golden Age Health and Innostellar Biotherapeutics Sign Exclusive 10-Year Collaboration to Accelerate LX-101 Gene Therapy for Inherited Retinal Dystrophies due to RPE 65 gene mutation in Mainland China
SHANGHAI–(BUSINESS WIRE)–Golden Age Health Pte. Ltd. (“GAH”) and Innostellar Biotherapeutics Co., Ltd. (“Innostellar”) today announced an exclusive ten-year Promotion Services Agreement that grants GAH sole rights to commercialise and promote Innoste…
Lock In Instant Definition and Volume with COVERGIRL’s NEW Mascara
NEW YORK–(BUSINESS WIRE)–Get ready to lock in lashes that feel stronger and protected with COVERGIRL’s latest addition to the Lash Blast portfolio. Say hello to NEW Lash Blast Bond Mascara, formulated to deliver instant definition and up to 5x visibl…
Glaukos to Release Second Quarter 2025 Financial Results after Market Close on July 30
ALISO VIEJO, Calif.–(BUSINESS WIRE)–Glaukos Corporation (NYSE: GKOS), an ophthalmic pharmaceutical and medical technology company focused on novel therapies for the treatment of glaucoma, corneal disorders and retinal diseases, plans to release secon…
Samenvatting: Doorbraak in de oogheelkunde! Heng Qin® (perfluorohexyloctaan oogdruppels) van Hengrui goedgekeurd als eerste behandeling voor droge ogen geassocieerd met MGD
JIANGSU, China & HEIDELBERG, Germany & CAMBRIDGE, Mass.–(BUSINESS WIRE)–Jiangsu Hengrui Pharmaceuticals Co., Ltd. (‘Hengrui Pharma’), een wereldwijd farmaceutisch bedrijf gericht op wetenschappelijke en technologische innovatie, en Novaliq GmbH (‘Nov…